(Q58389952)

1

0 references

Steve Simpson

2

0 references

Stephanie Knippenberg

3

0 references

Bruce V Taylor

Neurodegenerative disease management

5

0 references

publication date

December 2011

0 references

published in

0 references

volume

1

0 references

issue

6

0 references

page(s)

523-536

0 references

1 reference

Current disease-modifying treatment of multiple sclerosis

21 January 2018

1 reference

Treatment options for multiple sclerosis: current and emerging therapies

21 January 2018

1 reference

Therapeutic potential of vitamin D for multiple sclerosis

21 January 2018

1 reference

21 January 2018

1 reference

Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity

21 January 2018

1 reference

Modulation of the immune system by UV radiation: more than just the effects of vitamin D?

21 January 2018

1 reference

Vitamin effects on the immune system: vitamins A and D take centre stage

21 January 2018

1 reference

1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR

21 January 2018

1 reference

1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses

21 January 2018

1 reference

Vitamin D, innate immunity and upper respiratory tract infection

21 January 2018

1 reference

Vitamin D and innate and adaptive immunity

21 January 2018

1 reference

New clues about vitamin D functions in the nervous system

21 January 2018

1 reference

25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

21 January 2018

1 reference

Treatment with dexamethasone and vitamin D3 attenuates neuroinflammatory age-related changes in rat hippocampus

21 January 2018

1 reference

Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line

21 January 2018

1 reference

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

Vitamin D3 and brain development

21 January 2018

1 reference

Developmental vitamin D deficiency causes abnormal brain development.

21 January 2018

1 reference

Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide.

21 January 2018

1 reference

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity

21 January 2018

1 reference

Vitamin D in African Americans with multiple sclerosis.

21 January 2018

1 reference

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers.

21 January 2018

1 reference

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

21 January 2018

1 reference

Geography in multiple sclerosis

21 January 2018

1 reference

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

21 January 2018

1 reference

Frequency of multiple sclerosis in three Australian cities--Perth, Newcastle, and Hobart

21 January 2018

1 reference

The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart

21 January 2018

1 reference

Occurrence of multiple sclerosis in the north and south of New Zealand

21 January 2018

1 reference

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

Sun exposure and vitamin D are independent risk factors for CNS demyelination

21 January 2018

1 reference

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

21 January 2018

1 reference

Individual and joint action of environmental factors and risk of MS.

21 January 2018

1 reference

Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins

21 January 2018

1 reference

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

21 January 2018

1 reference

Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates

21 January 2018

1 reference

Skin cancer in people with multiple sclerosis: a record linkage study

21 January 2018

1 reference

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

Time of birth, residential solar radiation and age at onset of multiple sclerosis

21 January 2018

1 reference

Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis.

21 January 2018

1 reference

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

Monthly ambient sunlight, infections and relapse rates in multiple sclerosis

21 January 2018

1 reference

Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.

21 January 2018

1 reference

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

21 January 2018

1 reference

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis

21 January 2018

1 reference

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

21 January 2018

1 reference

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

21 January 2018

1 reference

Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients

21 January 2018

1 reference

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

Depression and anxiety amongst multiple sclerosis patients.

21 January 2018

1 reference

Cognitive impairment in multiple sclerosis

21 January 2018

1 reference

Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners

21 January 2018

1 reference

Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.

21 January 2018

1 reference

Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

Association of vitamin D levels with incident depression among a general cardiovascular population.

21 January 2018

1 reference

Immunomodulatory actions of 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

21 January 2018

1 reference

Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat.

21 January 2018

1 reference

Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences

21 January 2018

1 reference

Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage

21 January 2018

1 reference

Increased anxiety in mice lacking vitamin D receptor gene

21 January 2018

1 reference

Correlates of symptoms of depression and anxiety in chronic hemodialysis patients.

21 January 2018

1 reference

Annual high-dose vitamin D3 and mental well-being: randomised controlled trial.

21 January 2018

1 reference

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain

21 January 2018

1 reference

Vitamin D is associated with cognitive function in elders receiving home health services

21 January 2018

1 reference

Vitamin D and risk of cognitive decline in elderly persons

21 January 2018

1 reference

Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease

21 January 2018

1 reference

A cross-sectional study of bone health in multiple sclerosis

21 January 2018

1 reference

Fracture history and bone loss in patients with MS.

21 January 2018

1 reference

The risk of fracture in patients with multiple sclerosis: the UK general practice research database

21 January 2018

1 reference

Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury

21 January 2018

1 reference

Osteoporosis in multiple sclerosis

21 January 2018

1 reference

Injurious falls among middle aged and older adults with multiple sclerosis

21 January 2018

1 reference

Risk factors for falling among people aged 45 to 90 years with multiple sclerosis.

21 January 2018

1 reference

Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?

21 January 2018

1 reference

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

21 January 2018

1 reference

Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.

21 January 2018

1 reference

Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial

21 January 2018

1 reference

Clinical viral infections and multiple sclerosis.

21 January 2018

1 reference

Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults

21 January 2018

1 reference

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression

21 January 2018

1 reference

Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3

21 January 2018

1 reference

Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren

21 January 2018

1 reference

Vitamin D signaling, infectious diseases, and regulation of innate immunity

21 January 2018

1 reference

Human herpes virus 6 and multiple sclerosis

21 January 2018

1 reference

Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production

21 January 2018

1 reference

A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.

21 January 2018

1 reference

Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis

21 January 2018

1 reference

Cigarette smoking and the progression of multiple sclerosis.

21 January 2018

1 reference

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

21 January 2018

1 reference

A meta-analysis of the effects of cigarette smoking on bone mineral density

21 January 2018

1 reference

Clinical practice. Vitamin D insufficiency

21 January 2018

1 reference

Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults

21 January 2018

1 reference

Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis

21 January 2018

1 reference